PDB Short entry for 2JOA HEADER PROTEIN BINDING 01-MAR-07 2JOA TITLE HTRA1 BOUND TO AN OPTIMIZED PEPTIDE: NMR ASSIGNMENT OF PDZ DOMAIN AND TITLE 2 LIGAND RESONANCES COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE PROTEASE HTRA1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PDZ DOMAIN, RESIDUES 379-480; COMPND 5 SYNONYM: L56, SERINE PROTEASE 11; COMPND 6 EC: 3.4.21.-; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PEPTIDE H1-C1; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HTRA1, HTRA, PRSS11; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630; SOURCE 15 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE PEPTIDE SOURCE 16 WAS DERIVED FROM A PHAGE-DISPLAYED LIBRARY AS AN OPTIMAL LIGAND FOR SOURCE 17 BINDING TO THE PDZ DOMAIN OF HUMAN HTRA1. KEYWDS PDZ, BETA-SANDWICH, CYCLICALLY-PERMUTED, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.T.RUNYON,Y.ZHANG,B.A.APPLETON,S.L.SAZINKSY,P.WU,B.PAN,C.WIESMANN, AUTHOR 2 N.J.SKELTON,S.S.SIDHU REVDAT 5 20-DEC-23 2JOA 1 REMARK REVDAT 4 14-JUN-23 2JOA 1 REMARK REVDAT 3 05-FEB-20 2JOA 1 SOURCE REMARK SEQADV REVDAT 2 24-FEB-09 2JOA 1 VERSN REVDAT 1 20-NOV-07 2JOA 0 JRNL AUTH S.T.RUNYON,Y.ZHANG,B.A.APPLETON,S.L.SAZINSKY,P.WU,B.PAN, JRNL AUTH 2 C.WIESMANN,N.J.SKELTON,S.S.SIDHU JRNL TITL STRUCTURAL AND FUNCTIONAL ANALYSIS OF THE PDZ DOMAINS OF JRNL TITL 2 HUMAN HTRA1 AND HTRA3 JRNL REF PROTEIN SCI. V. 16 2454 2007 JRNL REFN ISSN 0961-8368 JRNL PMID 17962403 JRNL DOI 10.1110/PS.073049407 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.T.RUNYON,B.PAN,N.J.SKELTON REMARK 1 TITL HTRA1 BOUND TO AN OPTIMIZED PEPTIDE: NMR ASSIGNMENT OF PDZ REMARK 1 TITL 2 DOMAIN AND LIGAND RESONANCES REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE 2005 FOR LINUX, CNX 2002 REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRPIPE), ACCELRYS SOFTWARE INC. (CNX) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: FOLLOWED BY CARTESIAN DYNAMICS AND REMARK 3 MINIMIZATION REMARK 4 REMARK 4 2JOA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1000100082. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0.025 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM [U-15N] HTRA1-PDZ, 4 MM REMARK 210 SYNTHETIC PEPTIDE H1-C1, 90% H2O/ REMARK 210 10% D2O; 2 MM [U-13C; U-15N] REMARK 210 HTRA1-PDZ, 4 MM SYNTHETIC REMARK 210 PEPTIDE H1-C1, 90% H2O/10% D2O; REMARK 210 2 MM [U-13C; U-15N] HTRA1-PDZ, 4 REMARK 210 MM SYNTHETIC PEPTIDE H1-C1, 100% REMARK 210 D2O; 2 MM [U-10% 13C; U-99% 15N] REMARK 210 HTRA1-PDZ, 4 MM SYNTHETIC REMARK 210 PEPTIDE H1-C1, 100% D2O; 2 MM [U- REMARK 210 13C; U-15N] HTRA1-PDZ, 1.8 MM REMARK 210 SYNTHETIC PEPTIDE H1-C1, 90% H2O/ REMARK 210 10% D2O; 2 MM [U-13C; U-15N] REMARK 210 HTRA1-PDZ, 1.8 MM SYNTHETIC REMARK 210 PEPTIDE H1-C1, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HNCO; 3D HNCACB; 3D CBCA(CO)NH; REMARK 210 3D HN(CO)CA; 2D 1H-13C HSQC; 3D REMARK 210 1H-15N NOESY; 3D 1H-13C NOESY; REMARK 210 3D HCCH-TOCSY; 2D 1H-1H NOESY REMARK 210 13C,15N-FILTERED IN F1; 2D 1H-1H REMARK 210 TOCSY,13C,15N-FILTERED IN F1; 3D REMARK 210 1H-13C NOESY, 13C-FILTERED IN F1 REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY 3.11, MONTE 2.02, CYANA REMARK 210 2.0, TOPSPIN 1.3, TALOS, CNX 2002 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 377 -66.36 -152.14 REMARK 500 1 LYS A 380 93.15 61.35 REMARK 500 1 LEU A 390 89.49 -58.06 REMARK 500 1 ARG A 401 -70.09 -82.51 REMARK 500 1 ASP A 404 14.23 -142.80 REMARK 500 1 PRO A 406 179.95 -52.09 REMARK 500 1 ILE A 415 -68.68 -96.24 REMARK 500 1 GLU A 430 41.45 -94.48 REMARK 500 1 ASN A 431 28.54 -151.88 REMARK 500 1 ILE A 435 -46.64 -148.79 REMARK 500 1 VAL A 443 -42.81 -130.12 REMARK 500 1 PRO A 475 175.49 -58.06 REMARK 500 1 SER B 2 -74.54 -81.64 REMARK 500 1 ARG B 3 71.34 60.40 REMARK 500 2 HIS A 378 92.35 -171.96 REMARK 500 2 LEU A 390 84.05 -69.13 REMARK 500 2 ASP A 407 30.98 -98.31 REMARK 500 2 PRO A 419 6.87 -69.52 REMARK 500 2 LYS A 429 141.98 176.82 REMARK 500 2 ILE A 435 -49.47 -141.86 REMARK 500 2 ARG B 3 99.63 -65.50 REMARK 500 3 ILE A 383 -59.46 -135.38 REMARK 500 3 LEU A 390 95.98 47.26 REMARK 500 3 ASP A 404 28.41 -167.54 REMARK 500 3 PRO A 419 44.08 -83.93 REMARK 500 3 ASP A 420 35.16 -173.31 REMARK 500 3 ILE A 435 -46.18 -136.43 REMARK 500 3 VAL A 443 -48.31 -139.45 REMARK 500 3 PRO A 475 -172.71 -66.84 REMARK 500 3 TRP B 6 85.93 -68.24 REMARK 500 4 MET A 379 97.05 59.39 REMARK 500 4 LEU A 390 81.41 -63.93 REMARK 500 4 PRO A 406 -167.29 -59.27 REMARK 500 4 ILE A 415 -61.24 -91.84 REMARK 500 4 ASP A 420 40.87 178.25 REMARK 500 4 ASN A 431 31.54 -165.17 REMARK 500 4 ILE A 435 -46.94 -138.69 REMARK 500 4 VAL A 443 -45.44 -133.76 REMARK 500 4 ASN A 466 20.56 -140.19 REMARK 500 5 HIS A 378 -76.29 66.42 REMARK 500 5 LEU A 390 98.55 -54.37 REMARK 500 5 ASP A 404 19.75 -146.97 REMARK 500 5 PRO A 406 -172.74 -65.92 REMARK 500 5 LEU A 428 -168.15 -108.12 REMARK 500 5 GLU A 430 49.93 -89.92 REMARK 500 5 ASN A 431 29.02 -160.46 REMARK 500 5 ILE A 435 -47.56 -141.95 REMARK 500 5 ASN A 466 30.89 -140.26 REMARK 500 5 SER B 2 47.20 -97.72 REMARK 500 5 ARG B 3 89.05 -61.62 REMARK 500 REMARK 500 THIS ENTRY HAS 204 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15154 RELATED DB: BMRB REMARK 900 RELATED ID: 2P3W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HTRA3 PDZ DOMAIN BOUND TO A PHAGE-DERIVED REMARK 900 LIGAND (FGRWV) DBREF 2JOA A 380 480 UNP Q92743 HTRA1_HUMAN 380 480 DBREF 2JOA B 1 7 PDB 2JOA 2JOA 1 7 SEQADV 2JOA GLY A 376 UNP Q92743 EXPRESSION TAG SEQADV 2JOA SER A 377 UNP Q92743 EXPRESSION TAG SEQADV 2JOA HIS A 378 UNP Q92743 EXPRESSION TAG SEQADV 2JOA MET A 379 UNP Q92743 EXPRESSION TAG SEQRES 1 A 105 GLY SER HIS MET LYS LYS TYR ILE GLY ILE ARG MET MET SEQRES 2 A 105 SER LEU THR SER SER LYS ALA LYS GLU LEU LYS ASP ARG SEQRES 3 A 105 HIS ARG ASP PHE PRO ASP VAL ILE SER GLY ALA TYR ILE SEQRES 4 A 105 ILE GLU VAL ILE PRO ASP THR PRO ALA GLU ALA GLY GLY SEQRES 5 A 105 LEU LYS GLU ASN ASP VAL ILE ILE SER ILE ASN GLY GLN SEQRES 6 A 105 SER VAL VAL SER ALA ASN ASP VAL SER ASP VAL ILE LYS SEQRES 7 A 105 ARG GLU SER THR LEU ASN MET VAL VAL ARG ARG GLY ASN SEQRES 8 A 105 GLU ASP ILE MET ILE THR VAL ILE PRO GLU GLU ILE ASP SEQRES 9 A 105 PRO SEQRES 1 B 7 ASP SER ARG ILE TRP TRP VAL HELIX 1 1 THR A 391 HIS A 402 1 12 HELIX 2 2 THR A 421 GLY A 427 1 7 HELIX 3 3 SER A 444 GLU A 455 1 12 SHEET 1 A 4 VAL A 433 ILE A 434 0 SHEET 2 A 4 ALA A 412 VAL A 417 -1 N ALA A 412 O ILE A 434 SHEET 3 A 4 ILE A 385 SER A 389 -1 N ARG A 386 O ILE A 415 SHEET 4 A 4 ILE B 4 TRP B 6 -1 O TRP B 5 N MET A 387 SHEET 1 B 2 LEU A 458 ARG A 464 0 SHEET 2 B 2 GLU A 467 VAL A 473 -1 O ILE A 471 N MET A 460 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000